Company profile: Prism Pharma
1.1 - Company Overview
Company description
- Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prism Pharma
Mobilion Systems
HQ: United States
Website
- Description: Provider of high-resolution ion mobility mass spectrometry and targeted molecular analyses to identify and analyze challenging molecules that other instruments so far have failed to detect. Offers MOBIE for rapid, high-resolution separation and identification, plus targeted lipidomics, targeted proteomics, glycomics, metabolomics, and therapeutic oligonucleotide analysis for disease research, diagnostics, biomarker discovery, and therapeutic development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mobilion Systems company profile →
Nextal Biotech
HQ: United States
Website
- Description: Provider of products designed for experimental crystallization needs, offering plates with grease-free, independent, screwable crystallization supports.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextal Biotech company profile →
Thesan Pharmaceuticals
HQ: United States
Website
- Description: Provider of preclinical biopharmaceutical development focused on novel therapeutics for skin disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thesan Pharmaceuticals company profile →
Avitide
HQ: United States
Website
- Description: Provider of customized affinity purification solutions for biopharmaceuticals, including AVIPure affinity resins for custom and platform use, proprietary solutions to improve bioprocessing and manufacturing, a flexible, scalable commercial resin supply supported by ISO 9001:2015 operations, regulatory support and documentation, and AVIPure-AAV8 for single-step AAV8 purification with high yield, purity, and capacity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avitide company profile →
CC Bio
HQ: United Kingdom
Website
- Description: Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CC Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prism Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prism Pharma
2.2 - Growth funds investing in similar companies to Prism Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prism Pharma
4.2 - Public trading comparable groups for Prism Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →